From CVS Health CEO Larry Merlo on plans to roll out Covid-19 vaccine · · CNBC Television
“We've been hiring individuals since this pandemic began. In the next week or so, we'll be at nine million COVID tests administered in communities across the country, including many of our underserved communities where we've been able to bring access to testing to minority populations.”
On , Larry Merlo, Former President & Chief Executive Officer at CVS Health, spoke about testing capacity during CVS Health CEO Larry Merlo on plans to roll out Covid-19 vaccine on CNBC Television.
Larry Merlo, former President and CEO of CVS Health, stated that the company was prepared to begin administering COVID-19 vaccinations within 48 hours of receiving a vaccine allocation. He said that CVS had been working with Operation Warp Speed and the CDC, and that the company's first involvement would be in long-term care facilities, with 10,000 healthcare professionals ready to administer the vaccine. Merlo also noted that CVS had conducted over seven million COVID-19 tests and had built mobile kiosks to bring testing to underserved communities. Merlo discussed CVS Health's acquisition of Aetna, describing it as an opportunity to create a new healthcare platform that is simpler and less expensive for consumers. He said that the combination of CVS and Aetna would allow the company to become more of a healthcare destination, addressing chronic disease management and reducing overall healthcare costs. Merlo also addressed the opioid crisis, stating that CVS would "vigorously defend" its actions and that the company was not "on the hook" for the crisis.